Suzhou ASTRABIO Co., Ltd.

Advancing Alzheimer’s disease research in China: insights, innovations, and future directions from the chinese preclinical Alzheimer’s disease study (CPAS) 【Abstract】 Th...

Multiparity exacerbates Aβ accumulation and promotes cellular senescence in a mouse model of amyloidosis 【Abstract】 【Background】 Women have nearly twice the lifeti...

Entorhinal cortex atrophy mediates the association of plasma p-tau181, GFAP, and NfL with cognitive impairment in Parkinson’s disease 【Abstract】 【Background】 Cogni...

Association of mitochondrial genome variants with Alzheimer's disease in a Chinese population 【Abstract】 【Background】 Research on the mitochondrial genome var...

 Engineered Alzheimer Organoids Validate the Link Between Intracellular and Soluble p‑Tau Biomarkers and Highlight the Contribution of Astrocytic Tau 【Abstract】 Sol...

Multidimensional modeling of biological aging: integrating gait, eye movement, rest-state functional connectivity, and plasma biomarkers in non-dementia older adults 【Abstra...

A prospective real-world study of the efficacy and safety of aducanumab in China: Focus on early-onset and autosomal dominant Alzheimer's disease 【Highlights】 1、...

Plasma biomarker changes following deep cervical lymphatic venous anastomosis An exploratory study in Alzheimer's disease using single-molecule array technology 【Abstra...